Carregant...
Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
It has been said that COVID-19 is a generational challenge in many ways. But, at the same time, it becomes a catalyst for collective action, innovation, and discovery. Realizing the full potential of artificial intelligence (AI) for structure determination of unknown proteins and drug discovery are...
Guardat en:
| Publicat a: | Curr Res Pharmacol Drug Discov |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8317454/ https://ncbi.nlm.nih.gov/pubmed/34870150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.crphar.2021.100042 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|